vt3989
vivace therapeutics
['mesothelioma', 'vt3989']
 these are early but very promising results showing that this previously undruggable target and anti-cancer strategy can work in a clinical setting, says our dr. timothy yap of yap/tead inhibitor vt3989 for mesothelioma. #aacr23 #endcancer
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789